FDA Approves Bupropion/Naltrexone (Contrave) for ObesityFDA Approves Bupropion/Naltrexone (Contrave) for Obesity

After a rocky start, the FDA has finally approved the obesity medication, but with a boxed warning about the risk for suicidal thoughts and serious neuropsychiatric events. FDA Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news